JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1993) 137, 1-5    DOI: 10.1677/joe.0.1370001
© 1993 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Strain, A. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Strain, A. J.

Hepatocyte growth factor: another ubiquitous cytokine

A. J. Strain

Novel growth factors have often been given names which relate to their original site of discovery or their first known target cell or biological action. Subsequent studies have frequently shown such nomenclature to be misleading as more is learned about the factor concerned. Epidermal growth factor (EGF) and fibroblast growth factor (FGF) which in fact act as mitogens for a great variety of cell types and transforming growth factor-β (TGFβ) which is better recognized as a growth inhibitor are all typical examples. Moreover, in addition to their growth regulatory roles, peptide growth factors also serve to modulate cell differentiation and function. The recently characterized hepatocyte growth factor (HGF) joins this illustrious family of cytokines which have proven rather more versatile than their original descriptive title suggests.

Characterization: Hepatocyte growth factor was originally identified and characterized by three independent experimental approaches.

(a) Michalopoulos described a mitogenic activity in the serum of




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Blanquaert, R. C. Pereira, and E. Canalis
Cortisol inhibits hepatocyte growth factor/scatter factor expression and induces c-met transcripts in osteoblasts
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E509 - E515.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Blanquaert, A. M. Delany, and E. Canalis
Fibroblast Growth Factor-2 Induces Hepatocyte Growth Factor/Scatter Factor Expression in Osteoblasts
Endocrinology, March 1, 1999; 140(3): 1069 - 1074.
[Abstract] [Full Text]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Society for Endocrinology.